CD8A and neoplasm: Genetic ablation of NRP2 in TAMs impaired clearance of apoptotic tumor cells, resulting in secondary necrosis and subsequent inflammation within tumors leading to increased CD8+ T cell and NK cell recruitment and delayed tumor growth (19).